Search results
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
New York Times· 2 days agoPharmacy benefit managers are driving up drug costs for millions of people, employers and the...
Kirsten Axelsen: Affordable access to weight loss drugs needed (Opinion)
The Charleston Gazette· 3 days agoSen. Bernie Sanders, I-Vt., is getting a piece of the attention being paid to weight loss drugs. Unsurprisingly, these medicines have gotten a lot of notice; losing weight and keeping it off ...
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
NBC Dallas Fort Worth· 5 days agoMore U.S. employers are covering a buzzy class of medications called GLP-1s for weight loss, a...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 2 days agoNotably, some companies are fighting back against plans for Medicare to begin negotiating the prices...
Amazon Pharmacy expands $5 monthly subscription to Medicare patients By Reuters
Investing.com· 5 days agoAmazon has worked to lure customers away from more established pharmacies like CVS and Walgreens...
58% Of Patients Discontinue Use Of Obesity Meds Before Reaching Meaningful Weight Loss, Study Shows
Forbes· 3 days agoThere is high demand for obesity medications known as glucagon-like peptide-1 agonists, or GLP-1s. In conjunction with an appropriate diet and exercise regimen, GLP-1s can provide substantial ...
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
CNBC· 5 days agoMore U.S. employers are covering a buzzy class of medications called GLP-1s for weight loss, a...
Gateway - Quartz
Quartz· 5 days agoAfter dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, a Germany-based drug
The Supreme Court overturned Roe v. Wade 2 years ago. Here’s what’s happened since
CNN via Yahoo News· 22 hours agoTwo years ago, the US Supreme Court overturned Roe v. Wade, ending the constitutional right to an...
Gateway - Quartz
Quartz· 5 days agoPharmaceutical giant AbbVie was able to delay competition to its blockbuster arthritis drug, Humira, into the US market for many years. Although biosimilars will sell at a ...
